NASDAQ:BVS

Bioventus Stock Insider Trading

Healthcare > Medical - Devices

Buy BVS

*Your capital is at risk

$13.17

-0.0100 (-0.0759%)

At Close: Jul 31, 2026

Bioventus Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 76.37. In total, the insiders bought 3.06M and sold 150.33K BVS shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	76.37
● Buy	3.06M shares
● Sell	150.33K shares
83% Buy Activity Moderate Positive Correlation
Buy Signal High Confidence Jun 02, 2026 Analysis Breakdown: Strongly supported by a very high Insider Power Score of 76.37. Partially supported by a positive historical correlation. Confidence increased due to high data reliability score of 100. Supported by overwhelming buy-side pressure (83% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
Feb 15, 2026 Buy	Class A Common Stock M-Exempt	Singleton Mark Leonard SVP & CFO	C-Suite Officer	20 153 Value: $265.4K
Feb 15, 2026 Sell	Class A Common Stock F-InKind	Singleton Mark Leonard SVP & CFO	C-Suite Officer	9 429 Value: $78.0K
Feb 15, 2026 Buy	Restricted Stock Units M-Exempt	Singleton Mark Leonard SVP & CFO	C-Suite Officer	20 153 Value: $265.4K
Jan 09, 2026 Buy	Class A Common Stock M-Exempt	Claypoole Robert E President And CEO	CEO / President	93 750 Value: $752.8K
Jan 09, 2026 Buy	Restricted Stock Units M-Exempt	Claypoole Robert E President And CEO	CEO / President	93 750 Value: $752.8K
Jan 09, 2026 Sell	Class A Common Stock F-InKind	Claypoole Robert E President And CEO	CEO / President	41 717 Value: $335.0K
Dec 04, 2025 Sell	Class A Common Stock S-Sale	Nohra Guy P Director	Director	10 000 Value: $75.7K
Nov 14, 2025 Buy	Class A Common Stock	Dhankhar Ajay Director	Director	0 Value: $0
Nov 07, 2025 Sell	Class A Common Stock S-Sale	Mcmurry-heath Michelle Director	Director	17 701 Value: $131.3K
Jun 06, 2025 Buy	Class A Common Stock M-Exempt	Bartholdson John A.	Director	7 575 Value: $50.7K
Jun 06, 2025 Buy	Restricted Stock Units M-Exempt	Bartholdson John A.	Director	7 575 Value: $50.7K
Jun 06, 2025 Buy	Restricted Stock Units M-Exempt	Bartholdson John A.	Director	7 575 Value: $50.7K
Jun 06, 2025 Buy	Class A Common Stock M-Exempt	Bartholdson John A.	Director	7 575 Value: $50.7K
Jun 03, 2025 Buy	Restricted Stock Units A-Award	Bartholdson John A.	Director	32 282 Value: $215.0K
Jun 02, 2025 Buy	Class A Common Stock M-Exempt	Bartholdson John A.	Director	26 493 Value: $170.6K
Mar 14, 2025 Buy	Restricted Stock Units A-Award	Singleton Mark Leonard SVP & CFO	C-Suite Officer	54 000 Value: $518.9K
Mar 14, 2025 Buy	Stock Option (Right to Buy) A-Award	Singleton Mark Leonard SVP & CFO	C-Suite Officer	61 000 Value: $586.2K
Mar 14, 2025 Buy	Stock Option (Right to Buy) A-Award	Church Katrina J SVP & Chief Compliance Officer	Officer	16 000 Value: $153.8K
Mar 14, 2025 Buy	Restricted Stock Units A-Award	Church Katrina J SVP & Chief Compliance Officer	Officer	14 000 Value: $134.5K
Mar 14, 2025 Buy	Stock Option (Right to Buy) A-Award	D'adamio Anthony SVP & General Counsel	Officer	40 000 Value: $384.4K
Mar 14, 2025 Buy	Restricted Stock Units A-Award	D'adamio Anthony SVP & General Counsel	Officer	35 000 Value: $336.4K
Mar 14, 2025 Buy	Stock Option (Right to Buy) A-Award	Claypoole Robert E President And CEO	CEO / President	153 000 Value: $1.47M
Mar 14, 2025 Buy	Restricted Stock Units A-Award	Claypoole Robert E President And CEO	CEO / President	134 000 Value: $1.29M
Apr 01, 2021 Buy	Restricted Stock Units A-Award	Cowdy Philip G. Director	Director	2 700 Value: $0
Feb 11, 2021 Buy	Restricted Stock Units A-Award	Cowdy Philip G. Director	Director	9 000 Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT BIOVENTUS INC.

Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products. Its surgical solutions comprise bone graft substitutes to fuse and grow bones,...

Read Full Profile Here